Dolci Marco
Known title: SVP Global Operations, R&DCIK: 0001798597
Associated companies
Transaction History
| LIVN | ▲ Buy | Option Exercise | 514 | $0 | 3/30/2023 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 222 | $9K | 3/30/2023 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 1,434 | $0 | 3/30/2023 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 617 | $26K | 3/30/2023 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 853 | $0 | 3/30/2023 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 367 | $16K | 3/30/2023 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 762 | $0 | 3/30/2023 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 328 | $14K | 3/30/2023 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 4,188 | $0 | 2/27/2023 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 1,801 | $86K | 2/27/2023 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 1,761 | $0 | 2/27/2023 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 758 | $36K | 2/27/2023 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 514 | $0 | 3/30/2022 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 222 | $18K | 3/30/2022 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 1,434 | $0 | 3/30/2022 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 617 | $50K | 3/30/2022 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 853 | $0 | 3/30/2022 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 367 | $30K | 3/30/2022 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 558 | $0 | 3/15/2022 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 240 | $17K | 3/15/2022 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 688 | $0 | 3/1/2022 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 312 | $24K | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
LivaNova Shares Rise on Barclays Overweight Rating
Barclays has begun coverage of LivaNova, giving it an overweight rating and a $105 price target. The stock is currently trading near the upper end of its 52‑week range and has been on a 60% three‑year run, which some analysts see as undervalued. Technical indicators show an RSI of 45 and a support level at $78.13, with a support reject signal that may signal a short‑term consolidation.
LivaNova Shares Rise on Barclays Overweight Rating. Barclays has begun coverage of LivaNova, giving it an overweight rating and a $105 price target. The stock is currently trading near the upper end of its 52‑week range and has been on a 60% three‑year run, which some analysts see as undervalued. Technical indicators show an RSI of 45 and a support level at $78.13, with a support reject signal that may signal a short‑term consolidation.